International Registry of Stem Cell Treatment Providers  ·  2026 Clinical Edition  ·  1,507 Verified Clinics Across 73 Countries
StemCell Registry
Global Clinical Directory
1,507 Providers
73 Countries
Edition 2026
FAQ
StemCell RegistryJapan › Cell Grand Clinic Osaka

Cell Grand Clinic Osaka

A regenerative medicine clinic in Shinsaibashi, central Osaka, offering stem cell therapy from the patient's own fat, exosomes and immune cell treatments.

Medical Disclaimer: This profile is compiled for informational purposes only and is not medical advice, a clinical endorsement, or a statement that any treatment is proven or approved. Stem cell therapies vary widely in regulatory status and evidence. Consult a qualified physician before pursuing treatment.

Overview

Cell Grand Clinic is a regenerative medicine clinic on the fourth floor of the Midosuji Minami building at 2-3-2 Nishi-Shinsaibashi in Chuo-ku, central Osaka. The site gives a full address, a telephone number and the name and background of its director, so the location is straightforward to check.

According to the site, the clinic's central treatment is stem cell therapy using mesenchymal stem cells cultured from the patient's own fat. It also offers exosome therapy prepared from stem cell culture supernatant, transplantation of the patient's own fibroblasts, natural killer cell therapy, a nicotinamide mononucleotide drip and platelet rich plasma prepared from the patient's own blood.

The site states that the clinic has fifteen regenerative medicine provision plans approved by Japan's Ministry of Health, Labour and Welfare. Under Japanese law a clinic must notify and have approved a plan for each regenerative treatment it provides, so this is a meaningful and checkable statement, though the directory has not independently confirmed it with the ministry.

The conditions the site lists include osteoarthritis of the knee, diabetes, hardening of the arteries, chronic pain, hair loss, erectile dysfunction, skin ageing, Alzheimer's disease and frailty. These are the conditions the site says it treats; that is not evidence the treatments work, and most of these uses are not established therapies. The site does not publish prices and says a consultation is needed first. It offers pages in English, Chinese, Korean, Indonesian, Vietnamese and Arabic as well as Japanese, and says multilingual staff are on site.

At a Glance

Location
Osaka (Shinsaibashi), Japan
Google Rating
5 ★ (34 reviews)
Languages
['Japanese', 'English', 'Chinese', 'Korean', 'Indonesian', 'Vietnamese', 'Arabic']

Services and Treatments Offered

  • Stem cell therapy using mesenchymal stem cells cultured from the patient's own fat
  • Exosome therapy from stem cell culture supernatant
  • Autologous fibroblast transplantation (using the patient's own skin cells)
  • Natural killer cell therapy
  • Nicotinamide mononucleotide therapy
  • Platelet rich plasma therapy (prepared from the patient's own blood)

Conditions Treated

The site lists the following among the conditions it treats.

Osteoarthritis of the kneeDiabetesHardening of the arteriesChronic painMale pattern hair lossErectile dysfunctionSkin ageingAlzheimer's diseaseFrailty

Cell Sources and Technologies

The site states that its stem cell treatment uses mesenchymal stem cells cultured from the patient's own fat, not donor cells.

Adipose-derived mesenchymal stem cells — described by the site as cultured from the patient's own fat (autologous, meaning from the patient's own body)Exosomes — described by the site as prepared from the supernatant left after culturing stem cellsFibroblasts — the patient's own skin cellsNatural killer cells — the patient's own immune cellsPlatelet rich plasma — prepared from the patient's own blood

Physicians and Clinical Team

The site names the clinic's director.

Dr Yuichi Wakabayashi — MD, PhD; clinic director. The site lists him as a graduate of Kobe University School of Medicine with a doctorate, a lecturer at Kindai University School of Medicine, a former research fellow at the National Institutes of Health in the United States, and a specialist physician of the American academy of regenerative medicine (name transliterated from Japanese)

Facility and Patient Experience

The site describes a clinic on the fourth floor of the Midosuji Minami building, also referred to as the Fendi building, at 2-3-2 Nishi-Shinsaibashi in Chuo-ku, Osaka, in the middle of the Shinsaibashi shopping district. It states that fifteen regenerative medicine provision plans have been approved by Japan's Ministry of Health, Labour and Welfare and that multilingual staff are available on site. The pages read do not name the laboratory that cultures the cells.

  • Address given on the site: 2-3-2 Nishi-Shinsaibashi, Chuo-ku, Osaka 542-0086, Midosuji Minami building, fourth floor
  • Telephone given on the site: 06-6212-5960
  • The site states that fifteen regenerative medicine provision plans are approved by Japan's Ministry of Health, Labour and Welfare
  • Site published in Japanese with English, Chinese (simplified and traditional), Korean, Indonesian, Vietnamese and Arabic versions
  • The site states that multilingual staff are available on site

Cost and Payment

The site does not publish prices and states that costs are discussed after a consultation with the doctor.

Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.

Other Providers in Japan

View all providers in Japan →